
    
      The Treatment Plan followed for all subjects will consist of:

        -  A Screening Visit within 14 days before study drug (fosbretabulin or placebo)
           administration

        -  A Treatment Phase of 21-day combination treatment (study drug plus chemotherapy) cycles
           (up to 6 cycles)

        -  An End of Treatment Phase assessment

        -  An End of Study Visit occurring 30 days after the last day of study drug administration,
           as able

      After the last clinic visit, all subjects will be followed for survival by monthly phone
      calls, email, or in-person.
    
  